|
Volumn 349, Issue 4, 2003, Pages 323-325
|
Aortic stenosis, von Willebrand factor, and bleeding
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METALLOPROTEINASE ADAM 13;
TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;
UNCLASSIFIED DRUG;
VON WILLEBRAND FACTOR;
AORTA STENOSIS;
AORTA VALVE REPLACEMENT;
BLEEDING;
CLINICAL FEATURE;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
ENDOTHELIUM CELL;
HEMOSTASIS;
HUMAN;
MICROVASCULATURE;
PATHOGENESIS;
PREVALENCE;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN STRUCTURE;
REVIEW;
SHEAR STRESS;
THROMBOCYTE;
TREATMENT OUTCOME;
VON WILLEBRAND DISEASE;
AORTA VALVE STENOSIS;
BLOOD RHEOLOGY;
CHEMISTRY;
HEART VALVE REPLACEMENT;
METABOLISM;
NOTE;
PATHOPHYSIOLOGY;
AORTIC VALVE STENOSIS;
BLOOD LOSS, SURGICAL;
HEART VALVE PROSTHESIS IMPLANTATION;
HEMORHEOLOGY;
HEMORRHAGE;
HUMANS;
VON WILLEBRAND DISEASE;
VON WILLEBRAND FACTOR;
|
EID: 0037778764
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp030055 Document Type: Review |
Times cited : (88)
|
References (1)
|